240 related articles for article (PubMed ID: 25088201)
1. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.
Ferguson B; Ram R; Handoko HY; Mukhopadhyay P; Muller HK; Soyer HP; Morahan G; Walker GJ
Oncogene; 2015 May; 34(22):2879-86. PubMed ID: 25088201
[TBL] [Abstract][Full Text] [Related]
2. Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
Chagani S; Wang R; Carpenter EL; Löhr CV; Ganguli-Indra G; Indra AK
BMC Cancer; 2017 Nov; 17(1):736. PubMed ID: 29121869
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis.
Ferguson B; Konrad Muller H; Handoko HY; Khosrotehrani K; Beermann F; Hacker E; Soyer HP; Bosenberg M; Walker GJ
Pigment Cell Melanoma Res; 2010 Dec; 23(6):771-80. PubMed ID: 20718941
[TBL] [Abstract][Full Text] [Related]
4. Melanoma progression.
Elder DE
Pathology; 2016 Feb; 48(2):147-54. PubMed ID: 27020387
[TBL] [Abstract][Full Text] [Related]
5. A blueprint for staging of murine melanocytic lesions based on the Cdk4 ( R24C/R24C ) ::Tyr- NRAS ( Q ) ( 61K ) model.
Wurm EM; Lin LL; Ferguson B; Lambie D; Prow TW; Walker GJ; Soyer HP
Exp Dermatol; 2012 Sep; 21(9):676-81. PubMed ID: 22742762
[TBL] [Abstract][Full Text] [Related]
6. CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma.
McNeal AS; Liu K; Nakhate V; Natale CA; Duperret EK; Capell BC; Dentchev T; Berger SL; Herlyn M; Seykora JT; Ridky TW
Cancer Discov; 2015 Oct; 5(10):1072-85. PubMed ID: 26183406
[TBL] [Abstract][Full Text] [Related]
7. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
Newton-Bishop JA; Chang YM; Iles MM; Taylor JC; Bakker B; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Elliott F; Kanetsky PA; Harland M; Barrett JH; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):2043-54. PubMed ID: 20647408
[TBL] [Abstract][Full Text] [Related]
8. Haplosufficiency of PAX3 for melanoma development in Tyr: NRASQ61K; Cdkn2a-/- mice allows identification and sorting of melanoma cells using a Pax3GFP reporter allele.
Campagne C; Reyes-Gomez E; Loiodice S; Gadin S; Ezagal J; Bernex F; Abitbol M; Louise A; Beermann F; Panthier JJ; Aubin-Houzelstein G; Egidy G
Melanoma Res; 2016 Feb; 26(1):12-20. PubMed ID: 26587692
[TBL] [Abstract][Full Text] [Related]
9. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
[TBL] [Abstract][Full Text] [Related]
11. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
Thomas NE; Edmiston SN; Alexander A; Millikan RC; Groben PA; Hao H; Tolbert D; Berwick M; Busam K; Begg CB; Mattingly D; Ollila DW; Tse CK; Hummer A; Lee-Taylor J; Conway K
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):991-7. PubMed ID: 17507627
[TBL] [Abstract][Full Text] [Related]
12. Different genetic mechanisms mediate spontaneous versus UVR-induced malignant melanoma.
Ferguson B; Handoko HY; Mukhopadhyay P; Chitsazan A; Balmer L; Morahan G; Walker GJ
Elife; 2019 Jan; 8():. PubMed ID: 30681412
[TBL] [Abstract][Full Text] [Related]
13. Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 mice.
Gaffal E; Landsberg J; Bald T; Sporleder A; Kohlmeyer J; Tüting T
Int J Cancer; 2011 Jul; 129(2):285-94. PubMed ID: 21207411
[TBL] [Abstract][Full Text] [Related]
14. The Genetic Evolution of Melanoma from Precursor Lesions.
Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
[TBL] [Abstract][Full Text] [Related]
15. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.
Demunter A; Stas M; Degreef H; De Wolf-Peeters C; van den Oord JJ
J Invest Dermatol; 2001 Dec; 117(6):1483-9. PubMed ID: 11886512
[TBL] [Abstract][Full Text] [Related]
16. Pathways to melanoma.
Ko JM; Velez NF; Tsao H
Semin Cutan Med Surg; 2010 Dec; 29(4):210-7. PubMed ID: 21277534
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the Cdon gene potentiates congenital nevus development mediated by NRAS(Q61K).
Chitsazan A; Ferguson B; Ram R; Mukhopadhyay P; Handoko HY; Gabrielli B; Soyer PH; Morahan G; Walker GJ
Pigment Cell Melanoma Res; 2016 Jul; 29(4):459-64. PubMed ID: 27155367
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4(R24C/R24C)/Tyr-Nras(Q61K) mice following neonatal UVR.
Hacker E; Muller HK; Hayward N; Fahey P; Walker G
Pigment Cell Melanoma Res; 2010 Feb; 23(1):121-8. PubMed ID: 19788533
[TBL] [Abstract][Full Text] [Related]
19. High BRAF mutation frequency does not characterize all melanocytic tumor types.
Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
[TBL] [Abstract][Full Text] [Related]
20. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
